Literature DB >> 19193911

Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Robert Udelsman1, Janice L Pasieka, Cord Sturgeon, J E M Young, Orlo H Clark.   

Abstract

CONTEXT: An international workshop on primary hyperparathyroidism (PHPT) was convened on May 13, 2008, to review and update the previous summary statement on the management of asymptomatic PHPT published in 2002. EVIDENCE ACQUISITION: Electronic literature sources were systematically reviewed, addressing critical aspects of the surgical issues pertaining to the indications, imaging, surgical treatment, and cost-effective management of patients with PHPT. EVIDENCE SYNTHESIS: The surgical group concluded that many patients with "asymptomatic" PHPT have neurocognitive symptoms that may be unmasked after successful parathyroidectomy. Furthermore, reduced bone density and increased fracture risk can be improved with parathyroidectomy. When PHPT is symptomatic, it may be associated with nephrolithiasis, increased cardiovascular disease, and decreased survival. Preoperative imaging studies should only be performed to help plan the operation, and negative imaging should never preclude surgical referral. Noninvasive localization studies including ultrasound and sestamibi scans are often employed, especially in anticipation of focused explorations. Invasive localization studies should be reserved for remedial explorations where noninvasive imaging has been unsuccessful.
CONCLUSIONS: When performed by expert parathyroid surgeons, parathyroid surgery is safe, cost-effective, and associated with very low perioperative morbidity. Minimally invasive approaches to parathyroid surgery appear to be as effective as the classic bilateral cervical exploration approach.

Entities:  

Mesh:

Year:  2009        PMID: 19193911     DOI: 10.1210/jc.2008-1761

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  45 in total

Review 1.  [Primary hyperparathyroidism - current diagnosis and therapy].

Authors:  Kristina Pluemacher; Heide Siggelkow
Journal:  Med Klin (Munich)       Date:  2010-08

2.  The utility of 99mTc-sestamibi scintigraphy in the localisation of parathyroid adenomas in primary hyperparathyroidism.

Authors:  N Glynn; N Lynn; C Donagh; R K Crowley; D Smith; C J Thompson; A D K Hill; F Keeling; A Agha
Journal:  Ir J Med Sci       Date:  2010-11-13       Impact factor: 1.568

3.  Hyperparathyroidism, an emerging disease.

Authors:  Guido Gasparri; Nicola Palestini; Silvia Catalano; Francesca Talarico; Clemente Ronchetta; Gregorio Balbo; Michele Camandona
Journal:  Updates Surg       Date:  2010-11-13

Review 4.  Clinical aspects of primary hyperparathyroidism: clinical manifestations, diagnosis, and therapy.

Authors:  Rudolf Wolfgang Gasser
Journal:  Wien Med Wochenschr       Date:  2013-08-29

5.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

6.  Endoscopic parathyroidectomy in primary hyperparathyroidism.

Authors:  Jean-Michel Prades; Alexander Asanau; Andrei P Timoshenko; Marie Gavid; Christian Martin
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-03       Impact factor: 2.503

7.  Parathyroid gland: Is parathyroidectomy safe and beneficial in the elderly?

Authors:  Neveen A T Hamdy
Journal:  Nat Rev Endocrinol       Date:  2009-08       Impact factor: 43.330

8.  Open mini-incision parathyroidectomy for solitary parathyroid adenoma.

Authors:  Ciaran W P Kelly; Chee-Yean Eng; M Shahed Quraishi
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-08       Impact factor: 2.503

Review 9.  Mild primary hyperparathyroidism: a literature review.

Authors:  Megan K Applewhite; David F Schneider
Journal:  Oncologist       Date:  2014-07-25

Review 10.  Primary hyperparathyroidism.

Authors:  Hafsah Al-Azem; Aliya Khan
Journal:  CMAJ       Date:  2011-04-26       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.